IP Library › Granted Patent US 8,202,551
Granted Patent B2
US 8,202,551 · App. 11/922,251 · Granted Jun 19, 2012

Tissue engineered cartilage, method of making same, therapeutic and cosmetic surgical applications using same

Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,202,551
App. No.
11/922,251
Granted
Jun 19, 2012
Kind
B2
Abstract

Cartilage has been constructed using biodegradable electrospun polymeric scaffolds seeded with chondrocytes or adult mesenchymal stem cells. More particularly engineered cartilage has been prepared where the cartilage has a biodegradable and biocompatible nanofibrous polymer support prepared by electrospinning and a plurality of chondocytes or mesenchymal stem cells dispersed in the pores of the support. The tissue engineered cartilages of the invention possess compressive strength properties similar to natural cartilage. Methods of preparing engineered tissues, including tissue engineered cartilages, are provided in which an electrospun nanofibrous polymer support is provided, the support is treated with a cell solution and the polymer-cell mixture cultured in a rotating bioreactor to generate the cartilage. The invention provides for the use of the tissue engineered cartilages in the treatment of cartilage degenerative diseases, reconstructive surgery, and cosmetic surgery.

Claims (7)

1. A tissue engineered cartilage, comprising

a nanofibrous polymer support comprising a plurality of polymer nanofibers; and

a plurality of chondrocytes dispersed throughout the polymer support, wherein the tissue engineered cartilage has a peak compressive stress (Young's modulus) of greater than 250 Mpa wherein the nanofibrous polymer support comprises a non-woven mat of electrospun nanofibers having a diameter of less than 1 micron, and wherein the nanofibers of the non-woven mat are randomly oriented.

2. The tissue engineered cartilage of claim 1 , wherein the nanofibrous polymer support comprises polymer nanofibers having a diameter of less than 1 micron.

3. The tissue engineered cartilage of claim 2 , wherein the polymer nanofibers have a diameter of between 50 nm and 1 micron.

4. The tissue engineered cartilage of claim 2 , wherein the polymer nanofibers have a substantially uniform diameter.

5. The tissue engineered cartilage of claim 1 , wherein the nanofibrous polymer support is composed of at least one biodegradable polyester or blend thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 23, 2009
From: LI, WAN-JU; TUAN, ROCKY S.
To: GOVERNMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 022621/0602 →
Continuity (2)
Provisional Application 60690988 · Jun 15, 2005
Related Publication 20100061962A1 · Mar 11, 2010